Anthony Petrone
Stock Analyst at Mizuho
(4.20)
# 477
Out of 5,103 analysts
201
Total ratings
56.16%
Success rate
12.36%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Outperform | $85 → $100 | $82.08 | +21.83% | 16 | Dec 5, 2025 | |
| AXGN Axogen | Initiates: Outperform | $40 | $30.39 | +31.62% | 1 | Dec 1, 2025 | |
| LIVN LivaNova | Maintains: Outperform | $65 → $70 | $62.75 | +11.55% | 9 | Nov 13, 2025 | |
| ALC Alcon | Maintains: Outperform | $110 → $100 | $78.80 | +26.90% | 11 | Nov 11, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Outperform | $70 → $85 | $72.50 | +17.24% | 8 | Nov 6, 2025 | |
| RMD ResMed | Maintains: Outperform | $310 → $300 | $252.27 | +18.92% | 18 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $90 → $100 | $83.08 | +20.37% | 10 | Oct 31, 2025 | |
| HOLX Hologic | Downgrades: Neutral | $70 → $78 | $75.00 | +4.00% | 10 | Oct 23, 2025 | |
| GH Guardant Health | Maintains: Outperform | $65 → $70 | $102.07 | -31.42% | 3 | Sep 25, 2025 | |
| HAE Haemonetics | Maintains: Outperform | $90 → $70 | $83.49 | -16.16% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $70 | $66.62 | +5.07% | 6 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $135 | $126.88 | +6.40% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $140 → $135 | $125.46 | +7.60% | 6 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $18 | $24.13 | -25.40% | 8 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $98 → $100 | $99.87 | +0.13% | 7 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $12 | $11.80 | +1.69% | 3 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $100 | $66.96 | +49.34% | 2 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $200 → $175 | $108.88 | +60.73% | 10 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $6.85 | +483.94% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $20 | $21.39 | -6.50% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $60 | $101.50 | -40.89% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $58 | $81.35 | -28.70% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $110 | $92.58 | +18.82% | 8 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $14 | $19.78 | -29.22% | 6 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $105 | $83.96 | +25.06% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 | $130.68 | +91.31% | 6 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $7.23 | +93.64% | 4 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $390 | $542.32 | -28.09% | 6 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $84.00 | -20.24% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $91.59 | +91.07% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $11.71 | +113.49% | 3 | May 13, 2020 |
The Cooper Companies
Dec 5, 2025
Maintains: Outperform
Price Target: $85 → $100
Current: $82.08
Upside: +21.83%
Axogen
Dec 1, 2025
Initiates: Outperform
Price Target: $40
Current: $30.39
Upside: +31.62%
LivaNova
Nov 13, 2025
Maintains: Outperform
Price Target: $65 → $70
Current: $62.75
Upside: +11.55%
Alcon
Nov 11, 2025
Maintains: Outperform
Price Target: $110 → $100
Current: $78.80
Upside: +26.90%
Establishment Labs Holdings
Nov 6, 2025
Maintains: Outperform
Price Target: $70 → $85
Current: $72.50
Upside: +17.24%
ResMed
Oct 31, 2025
Maintains: Outperform
Price Target: $310 → $300
Current: $252.27
Upside: +18.92%
Edwards Lifesciences
Oct 31, 2025
Maintains: Outperform
Price Target: $90 → $100
Current: $83.08
Upside: +20.37%
Hologic
Oct 23, 2025
Downgrades: Neutral
Price Target: $70 → $78
Current: $75.00
Upside: +4.00%
Guardant Health
Sep 25, 2025
Maintains: Outperform
Price Target: $65 → $70
Current: $102.07
Upside: -31.42%
Haemonetics
Aug 8, 2025
Maintains: Outperform
Price Target: $90 → $70
Current: $83.49
Upside: -16.16%
Aug 7, 2025
Maintains: Outperform
Price Target: $120 → $70
Current: $66.62
Upside: +5.07%
Aug 1, 2025
Maintains: Neutral
Price Target: $130 → $135
Current: $126.88
Upside: +6.40%
Jul 18, 2025
Maintains: Neutral
Price Target: $140 → $135
Current: $125.46
Upside: +7.60%
Jul 16, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $24.13
Upside: -25.40%
Jul 16, 2025
Maintains: Outperform
Price Target: $98 → $100
Current: $99.87
Upside: +0.13%
Jul 16, 2025
Maintains: Neutral
Price Target: $13 → $12
Current: $11.80
Upside: +1.69%
Jul 16, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $66.96
Upside: +49.34%
Apr 16, 2025
Maintains: Outperform
Price Target: $200 → $175
Current: $108.88
Upside: +60.73%
Apr 10, 2025
Initiates: Outperform
Price Target: $40
Current: $6.85
Upside: +483.94%
Apr 10, 2025
Initiates: Neutral
Price Target: $20
Current: $21.39
Upside: -6.50%
Apr 10, 2025
Initiates: Outperform
Price Target: $60
Current: $101.50
Upside: -40.89%
Mar 6, 2025
Maintains: Buy
Price Target: $54 → $58
Current: $81.35
Upside: -28.70%
Oct 24, 2024
Maintains: Outperform
Price Target: $100 → $110
Current: $92.58
Upside: +18.82%
Jun 20, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $19.78
Upside: -29.22%
May 1, 2024
Maintains: Buy
Price Target: $110 → $105
Current: $83.96
Upside: +25.06%
Mar 27, 2024
Maintains: Buy
Price Target: $250
Current: $130.68
Upside: +91.31%
Mar 1, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $7.23
Upside: +93.64%
Jan 25, 2024
Maintains: Neutral
Price Target: $350 → $390
Current: $542.32
Upside: -28.09%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $84.00
Upside: -20.24%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $91.59
Upside: +91.07%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $11.71
Upside: +113.49%